THE NEW FUND INSTITUTE FOR COLLABOR CANCER RESEARCH INC

EIN: 472485138 501(c)(3)

SAG HARBOR, NY

Total Revenue
$5,203
Total Expenses
$247,039
Total Assets
$254,883
Net Assets
$254,591
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2014
Legal Domicile
DE
Principal Officer
DUNCAN DARROW
Phone
6313240405
Tax Period
2019-01-01 to 2019-12-31

THE NEW FUND INSTITUTE FOR COLLABOR CANCER RESEARCH INC, founded in 2014, is a micro nonprofit that reported $5K in total revenue in fiscal year 2019. Revenue decreased 12% compared to the prior year. Expenses of $247K exceeded revenue, resulting in a 4648% operating deficit.

Mission

TO FUND SCIENTIFIC AND MEDICAL RESEARCH IN THE DISCOVERY AND DEVELOPMENT OF NEW MEDICINES FOR TREATING CANCER.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2019)

Revenue Breakdown

Contributions & Grants $0
Program Service Revenue $0
Investment Income $5,203
Other Revenue $0
TOTAL REVENUE $5,203

Expense Breakdown

Grants Paid $0
Salaries & Benefits $207,130
Fundraising Expenses $0
Program Expenses $168,318
Other Expenses $39,909
TOTAL EXPENSES $247,039

Year-over-Year Comparison

2019 2018 Change
Revenue $5,203 $5,882 -0.1%
Expenses $247,039 $308,908 -0.2%
Net Income $-241,836 $-303,026 -0.2%
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
4
Independent Members
3
Employees
1
Volunteers
2

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
4
$200,000
Total Directors
0
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
DUNCAN DARROW Chairman 40.00
Officer
$200,000 $0 $200,000
MARK PASSMANTIER MD Director 1.00
Officer
$0 $0 $0
ALAN JAKIMO Director 1.00
Officer
$0 $0 $0
JEREMY BLOOMER COO 1.00
Officer
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2019 $5,203 $247,039 $254,883 $-241,836
2018 $5,882 $308,908 $484,717 $-303,026
Explore More Nonprofits
→Top 100 Nonprofits in New York →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare THE NEW FUND INSTITUTE FOR COLLABOR CANCER RESEARCH INC with other nonprofits in New York and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.